{"id":"ether","rwe":[],"_fda":{"id":"21c70f99-2a67-415b-baea-9d46016850fa","set_id":"83825312-dff8-4caa-8afa-bb1eab7397f7","openfda":{"nui":["N0000185508","N0000175629","N0000184306","M0000728","M0005152","N0000175831","N0000008595","N0000008924","N0000175830"],"upc":["0649818024091"],"unii":["10LGE70FSU","597E9BI3Z3","S7V92P67HO","0R0008Q3JB","789U1901C5","1N41638RNO","1C89KKC04E","2P299V784P","FXS1BY2PGL","411VRN1TV4","R74O7T8569","A19RZC6BEH","O40UQP6WCF","39981FM375","29I4YB3S89","4JS0838828","3JYG22FD73"],"route":["ORAL"],"spl_id":["21c70f99-2a67-415b-baea-9d46016850fa"],"brand_name":["Enviro Detox Formula"],"spl_set_id":["83825312-dff8-4caa-8afa-bb1eab7397f7"],"package_ndc":["83027-0120-1"],"product_ndc":["83027-0120"],"generic_name":["LAPPA MAJOR, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SPINACIA, PETROLEUM, PLUMBUM METALLICUM, SULPHURICUM ACIDUM, AMMONIUM PHOSPHORICUM, ARSENICUM ALBUM, CHROMIUM (METALLICUM), CUPRUM METALLICUM, DIBROMOETHANE, KREOSOTUM, MERCURIUS VIVUS, MTBE (TERT-BUTYL METHYL ETHER), NITRICUM ACIDUM, RADIUM BROMATUM"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Allergens [CS]","Copper [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]","Decreased Embryonic Implantation [PE]","Decreased Sperm Motility [PE]","Inhibit Ovum Fertilization [PE]"],"substance_name":["AMMONIUM PHOSPHATE, DIBASIC","ARCTIUM LAPPA ROOT","ARSENIC TRIOXIDE","CHROMIUM","COPPER","ETHYLENE DIBROMIDE","KEROSENE","LEAD","MERCURY","NITRIC ACID","RADIUM BROMIDE","SPINACIA OLERACEA ROOT","SULFURIC ACID","TARAXACUM OFFICINALE","TERT-BUTYL METHYL ETHER","TRIFOLIUM PRATENSE FLOWER","WOOD CREOSOTE"],"pharm_class_epc":["Standardized Chemical Allergen [EPC]","Copper-containing Intrauterine Device [EPC]"],"manufacturer_name":["Nutritional Specialties, Inc."],"is_original_packager":[true]},"purpose":["PURPOSE: Aids in temporary relief of symptoms from exposure to miscellaneous air and water pollutants such as irregular bowel habits, nausea, difficulty sleeping, fatigue, and minor aches of muscles and joints.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"version":"1","warnings":["WARNINGS: Professional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening"],"questions":["QUESTIONS: MANUFACTURED EXCLUSIVELY FOR NUTRITIONAL SPECIALTIES, INC. PO BOX 97227 PITTSBURG, PA 15229 www.phpltd.com"],"effective_time":"20231006","active_ingredient":["ACTIVE INGREDIENTS: Lappa Major 3X, Taraxacum Officinale 3X, Trifolium Pratense 3X, Spinacia 6X, Petroleum 12X, 30X, 60X, 100X, Plumbum Metallicum 12X, 30X, 60X, 100X, Sulphuricum Acidum 12X, 30X, 60X, 100X, Ammonium Phosphoricum 30X, 60X, 100X, Arsenicum Album 30X, 60X, 100X, Chromium 30X, 60X, 100X, Cuprum Metallicum 30X, 60X, 100X, Dibromoethane 30X, 60X, 100X, Kreosotum 30X, 60X, 100X, Mercurius Vivus 30X, 60X, 100X, MTBE 30X, 60X, 100X, Nitricum Acidum 30X, 60X, 100X, Radium Bromatum 30X, 60X, 100X."],"inactive_ingredient":["INACTIVE INGREDIENTS: Alcohol USP 20%, Purified Water USP."],"indications_and_usage":["INDICATIONS: Aids in temporary relief of symptoms from exposure to miscellaneous air and water pollutants such as irregular bowel habits, nausea, difficulty sleeping, fatigue, and minor aches of muscles and joints.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"dosage_and_administration":["DIRECTIONS: Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. Do not take within 15 minutes of consuming food, beverage or brushing teeth. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Enviro Detox Formula Lappa Major, Taraxacum Officinale, Trifolium Pratense, Spinacia, Petroleum, Plumbum Metallicum, Sulphuricum acidum, Ammonium Phosphoricum, Arsenicum Album, chromium (Metallicum), Cuprum Metallicum, Dibromoethane, Kreosotum, Mercurius Vivus, MTBE (Tert-Butyl Methyl Ether), Nitricum Acidum, Radium Bromatum ARCTIUM LAPPA ROOT ARCTIUM LAPPA ROOT TARAXACUM OFFICINALE TARAXACUM OFFICINALE TRIFOLIUM PRATENSE FLOWER TRIFOLIUM PRATENSE FLOWER SPINACIA OLERACEA ROOT SPINACIA OLERACEA ROOT KEROSENE KEROSENE LEAD LEAD SULFURIC ACID SULFURIC ACID AMMONIUM PHOSPHATE, DIBASIC PHOSPHATE ION ARSENIC TRIOXIDE ARSENIC CATION (3+) CHROMIUM CHROMIUM COPPER COPPER ETHYLENE DIBROMIDE ETHYLENE DIBROMIDE WOOD CREOSOTE WOOD CREOSOTE MERCURY MERCURY TERT-BUTYL METHYL ETHER TERT-BUTYL METHYL ETHER NITRIC ACID NITRIC ACID RADIUM BROMIDE RADIUM CATION WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: Professional Health Products HOMEOPATHIC NDC 83027-0120-1 ENVIRO DETOX FORMULA 2 FL. OZ (60 ml) ENVIRO DETOX FORMULA"]},"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"APNOEA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"CEREBRAL INFARCTION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"INFLUENZA LIKE ILLNESS","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"RASH","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"STUPOR","source":"FDA FAERS","actionTaken":"1 reports"}],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{}},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ETHER","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:00:23.988230+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:00:58.358253+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:00:29.367898+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ETHER","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:00:29.762810+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:00:22.731228+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:00:22.731264+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:00:49.145502+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:00:22.731269+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:00:31.707583+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL487418/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:00:30.885919+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"241c7ffe-875a-deac-e063-6394a90a7878","title":"MELAO HOT CREAM (VANILLYL BUTYL ETHER 3% CAFFEINE 0.3%) CREAM [GUANGZHOU YILONG COSMETICS CO., LTD]"},"aiSummary":"ETHER is a marketed homeopathic preparation primarily indicated for the relief of irregular bowel habits. Its key strength lies in its unique mechanism of action based on the principle of 'like cures like,' which differentiates it from conventional treatments. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic homeopathic products.","ecosystem":[],"mechanism":{"target":"Not specified","novelty":"Low","modality":"Oral administration","drugClass":"Standardized Chemical Allergen [EPC]","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action for homeopathic remedies like Ether is not well understood and is not supported by scientific evidence. Homeopathy operates on the principle of 'similia similibus curentur' (let likes be cured by likes), which suggests that a substance that causes symptoms in a healthy person can treat similar symptoms in a sick person when administered in highly diluted form."},"_scrapedAt":"2026-03-28T03:06:38.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"yoyGrowth":"Not specified","launchDate":"Not specified","annualCostUS":"Not specified","currentRevenue":"Not specified","patientPopulation":"Not specified","peakSalesEstimate":"Not specified"},"references":[],"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:00:58.358366+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"indications":{"approved":[{"id":"ether-relief-of-irregular-bowel-habi","name":"Relief of irregular bowel habits","dosing":null,"approvals":[],"diseaseId":"","eligibility":"General population","pivotalTrial":null,"restrictions":[],"patientPopulation":"General population","diagnosticRequired":null,"brandNameForIndication":""},{"id":"ether-relief-of-nausea","name":"Relief of nausea","dosing":null,"approvals":[],"diseaseId":"","eligibility":"General population","pivotalTrial":null,"restrictions":[],"patientPopulation":"General population","diagnosticRequired":null,"brandNameForIndication":""},{"id":"ether-relief-of-difficulty-sleeping","name":"Relief of difficulty sleeping","dosing":null,"approvals":[],"diseaseId":"","eligibility":"General population","pivotalTrial":null,"restrictions":[],"patientPopulation":"General population","diagnosticRequired":null,"brandNameForIndication":""},{"id":"ether-relief-of-fatigue","name":"Relief of fatigue","dosing":null,"approvals":[],"diseaseId":"","eligibility":"General population","pivotalTrial":null,"restrictions":[],"patientPopulation":"General population","diagnosticRequired":null,"brandNameForIndication":""},{"id":"ether-relief-of-minor-aches-of-muscl","name":"Relief of minor aches of muscles and joints","dosing":null,"approvals":[],"diseaseId":"","eligibility":"General population","pivotalTrial":null,"restrictions":[],"patientPopulation":"General population","diagnosticRequired":null,"brandNameForIndication":""}],"offLabel":["Irregular bowel habits","Nausea","Difficulty sleeping","Fatigue","Minor aches of muscles and joints"],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07496593","phase":"PHASE4","title":"Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-01","conditions":"Diabete Mellitus, VATS, TIVA","enrollment":60},{"nctId":"NCT06669299","phase":"NA","title":"Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-06-12","conditions":"Ventricular Tachycardia (VT)","enrollment":51},{"nctId":"NCT04886960","phase":"PHASE1, PHASE2","title":"pAF for the Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-07-08","conditions":"Osteo Arthritis Knee","enrollment":60},{"nctId":"NCT03678350","phase":"PHASE1","title":"Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2021-09-17","conditions":"Malignant Mesothelioma, Non-Small Cell Lung Carcinoma, Pleural Disorder","enrollment":9},{"nctId":"NCT07445672","phase":"NA","title":"Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03-01","conditions":"Patient Cataract","enrollment":40},{"nctId":"NCT06565988","phase":"NA","title":"A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma","status":"COMPLETED","sponsor":"Bohus Biotech AB","startDate":"2024-09-02","conditions":"Midface Volume Deficit","enrollment":111},{"nctId":"NCT05327296","phase":"PHASE3","title":"Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)","status":"COMPLETED","sponsor":"Sedana Medical","startDate":"2022-06-30","conditions":"Sedation","enrollment":282},{"nctId":"NCT00342888","phase":"","title":"Case-Control Study of Pesticides and Childhood Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-10-30","conditions":"Leukemia","enrollment":629},{"nctId":"NCT05312385","phase":"PHASE3","title":"Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)","status":"COMPLETED","sponsor":"Sedana Medical","startDate":"2022-04-28","conditions":"Sedation","enrollment":277},{"nctId":"NCT03970720","phase":"PHASE2","title":"Restoration of Hypoglycemia Awareness With Metoclopramide","status":"RECRUITING","sponsor":"Simon Fisher","startDate":"2019-05-28","conditions":"Hypoglycemia Unawareness","enrollment":36},{"nctId":"NCT07226362","phase":"PHASE1","title":"A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults","status":"COMPLETED","sponsor":"Aspeya Switzerland SA","startDate":"2025-06-09","conditions":"Safety, and Tolerability","enrollment":44},{"nctId":"NCT07295158","phase":"NA","title":"Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Konya City Hospital","startDate":"2026-03-09","conditions":"Perioperative Respiratory Mechanics","enrollment":138},{"nctId":"NCT06353516","phase":"NA","title":"The Effect of Intravenous Versus Volatile Anesthesia on Postoperative Cognitive Dysfunction in Elderly Patients","status":"COMPLETED","sponsor":"Chung-Ang University Gwangmyeong Hospital","startDate":"2024-02-14","conditions":"Postoperative Cognitive Dysfunction","enrollment":154},{"nctId":"NCT06379217","phase":"PHASE1","title":"NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-29","conditions":"Metastatic Neuroendocrine Prostate Cancer","enrollment":31},{"nctId":"NCT07197567","phase":"","title":"Equivalent MAC in General Anesthesia","status":"COMPLETED","sponsor":"Sakarya University","startDate":"2025-11-01","conditions":"General Anesthesia, Intraoperative Monitoring, Anesthetic Depth","enrollment":60},{"nctId":"NCT07460050","phase":"NA","title":"Comparison of Two Sedative Agents in Terms of Controlled Hypotension","status":"NOT_YET_RECRUITING","sponsor":"Hayatabad Medical Complex","startDate":"2026-03-01","conditions":"Controlled Hypotension for Nasal Surgeries","enrollment":136},{"nctId":"NCT06044740","phase":"EARLY_PHASE1","title":"Sevoflurane's Effect on Neurocognition Study","status":"COMPLETED","sponsor":"Keith M Vogt","startDate":"2024-01-17","conditions":"Anesthesia, Pain, Amnesia","enrollment":42},{"nctId":"NCT02858310","phase":"PHASE1, PHASE2","title":"E7 TCR T Cells for Human Papillomavirus-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-27","conditions":"Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ","enrollment":224},{"nctId":"NCT07457593","phase":"","title":"Expanded Access for Inhaled Isoflurane Delivered Via the Sedaconda ACD-S for Sedation of Difficult-to-Sedate Adult Mechanically Ventilated Intensive Care Unit Patients","status":"AVAILABLE","sponsor":"Sedana Medical","startDate":"","conditions":"Sedation","enrollment":""},{"nctId":"NCT06252207","phase":"NA","title":"Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge","status":"WITHDRAWN","sponsor":"The Cleveland Clinic","startDate":"2023-12-08","conditions":"Surgery","enrollment":""},{"nctId":"NCT07450495","phase":"NA","title":"Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery","status":"RECRUITING","sponsor":"Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong","startDate":"2025-02-25","conditions":"Chalazion","enrollment":80},{"nctId":"NCT07208305","phase":"PHASE3","title":"Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting","status":"RECRUITING","sponsor":"Affiliated Hospital of Qinghai University","startDate":"2026-02-03","conditions":"Nausea, Vomiting","enrollment":222},{"nctId":"NCT07445737","phase":"PHASE3","title":"Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-06","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":700},{"nctId":"NCT07000526","phase":"PHASE4","title":"Inhaled Sedation in Critically Ill Patients","status":"RECRUITING","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2025-12-15","conditions":"Sedation, Airway Extubation","enrollment":620},{"nctId":"NCT07016308","phase":"NA","title":"Low-Flow Desflurane vs Sevoflurane: Impact on Physiology and Recoveryand Recovery Profiles in Adult ENT Surgery","status":"COMPLETED","sponsor":"Harran University","startDate":"2025-06-10","conditions":"Anesthesia, General","enrollment":40},{"nctId":"NCT07440758","phase":"NA","title":"Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy","status":"NOT_YET_RECRUITING","sponsor":"Kayseri City Hospital","startDate":"2026-03-20","conditions":"Laparoscopic Cholecystectomy, Postoperative Sore Throat","enrollment":70},{"nctId":"NCT02572791","phase":"PHASE4","title":"Staph Household Intervention for Eradication (SHINE)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-10","conditions":"Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus, MRSA - Methicillin Resistant Staphylococcus Aureus Infection","enrollment":835},{"nctId":"NCT07399223","phase":"NA","title":"Comparison of the Metabolomic Effects of Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy","status":"NOT_YET_RECRUITING","sponsor":"Harran University","startDate":"2026-02","conditions":"Sevoflurane Desflurane, Metabolomic Effect","enrollment":80},{"nctId":"NCT07421011","phase":"PHASE1","title":"Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.","status":"RECRUITING","sponsor":"Valenta Pharm JSC","startDate":"2025-11-06","conditions":"Irritable Bowel Syndrome, Gallstone Disease, GERD","enrollment":36},{"nctId":"NCT03489629","phase":"PHASE2","title":"STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-03","conditions":"Cystic Fibrosis","enrollment":37},{"nctId":"NCT07295054","phase":"PHASE4","title":"3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion","status":"NOT_YET_RECRUITING","sponsor":"Women's College Hospital","startDate":"2026-03","conditions":"IUD","enrollment":110},{"nctId":"NCT05583864","phase":"NA","title":"Lumbar Fusion With Porous Versus Non-Porous Cages","status":"ACTIVE_NOT_RECRUITING","sponsor":"Francis Farhadi","startDate":"2022-11-01","conditions":"Spinal Fusion, Lumbar Fusion, Arthrodesis","enrollment":108},{"nctId":"NCT07398924","phase":"NA","title":"Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2022-01-06","conditions":"Female Infertility, Anovulatory Infertility, Unexplained Infertility","enrollment":90},{"nctId":"NCT04710914","phase":"PHASE4","title":"Comparison of Extubation Delay After Prolonged Sedation","status":"TERMINATED","sponsor":"University Hospital, Rouen","startDate":"2020-12-15","conditions":"Septic Shock","enrollment":1},{"nctId":"NCT02851433","phase":"PHASE4","title":"Evaluate the Protective Effect of Conditioning With Sevoflurane on the Myocardium","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2015-10-14","conditions":"Cardiac Surgery","enrollment":82},{"nctId":"NCT04929379","phase":"PHASE2","title":"A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alessandro Doria","startDate":"2022-01-04","conditions":"Diabetic Nephropathies","enrollment":40},{"nctId":"NCT07388420","phase":"NA","title":"Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-02","conditions":"Hypertriglyceridemia Induced Acute Pancreatitis","enrollment":40},{"nctId":"NCT04836429","phase":"PHASE1","title":"Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2022-03-10","conditions":"Lung Non-Small Cell Carcinoma, Pleural Disorder","enrollment":5},{"nctId":"NCT06467279","phase":"","title":"Comparing Inhalation and Total Intravenous Anesthesia Methods","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2022-08-15","conditions":"Children, Hernia, Inguinal","enrollment":60},{"nctId":"NCT07304206","phase":"NA","title":"The Effects of Three Different Anesthetic Methods on Postoperative Agitation","status":"ENROLLING_BY_INVITATION","sponsor":"Inonu University","startDate":"2025-12-25","conditions":"Emergence Agitation, Septoplasty Surgeries","enrollment":3},{"nctId":"NCT07363681","phase":"NA","title":"Inhalational Agents Versus Dexmedetomidine for Maintenance of General Anesthesia","status":"RECRUITING","sponsor":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","startDate":"2024-10-01","conditions":"Ureterorenoscopic Lithotripsy, Transurethral Resection of the Bladder, Percutaneous Nephrolithotomy","enrollment":150},{"nctId":"NCT07359508","phase":"PHASE4","title":"Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2024-01-10","conditions":"Propofol Target-controlled Infusion, Desflurane, Optic Nerve Sheath Diameter","enrollment":146},{"nctId":"NCT01320345","phase":"PHASE3","title":"The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sydney","startDate":"2016-11-03","conditions":"Type 1 Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathies","enrollment":412},{"nctId":"NCT07271459","phase":"NA","title":"Effect of Total Intravenous Anesthesia vs Inhalational Anesthesia on the Level of Inflammatory Markers","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-02","conditions":"Anesthesia","enrollment":40},{"nctId":"NCT07343817","phase":"EARLY_PHASE1","title":"IV Injection of Metoclopramide With or Without Dexamethasone","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Nassar Ibrahim Mohammed","startDate":"2026-07-01","conditions":"Trauma Injury","enrollment":1},{"nctId":"NCT07338578","phase":"","title":"A Study Comparing Sevoflurane and Propofol in Patients Undergoing Endobronchial Ultrasound Guided Needle Aspiration","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2023-09-01","conditions":"Hemodynamic Stability, Pulmonary Diseases or Conditions, Complication of Anesthesia","enrollment":102},{"nctId":"NCT06210594","phase":"PHASE4","title":"Staph Intervention for Effective Local Defense","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-04-01","conditions":"Staphylococcus Aureus Infection","enrollment":78},{"nctId":"NCT06755151","phase":"PHASE3","title":"Fenofibrate in Primary Biliary Cholangitis: a Real World Study","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-01-17","conditions":"Primary Biliary Cholangitis (PBC)","enrollment":300},{"nctId":"NCT04630626","phase":"NA","title":"Post-Approval Study Protocol for the Simplify Cervical Artificial Disc","status":"COMPLETED","sponsor":"NuVasive","startDate":"2021-01-01","conditions":"Cervical Degenerative Disc Disorder","enrollment":145},{"nctId":"NCT06174402","phase":"PHASE2, PHASE3","title":"Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Han Ying","startDate":"2023-08-21","conditions":"Primary Biliary Cholangitis","enrollment":184},{"nctId":"NCT06755541","phase":"PHASE3","title":"Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-01-30","conditions":"Primary Biliary Cholangitis (PBC)","enrollment":150},{"nctId":"NCT05749822","phase":"PHASE2, PHASE3","title":"Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-02-17","conditions":"Primary Biliary Cholangitis","enrollment":104},{"nctId":"NCT04980378","phase":"","title":"Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc","status":"COMPLETED","sponsor":"NuVasive","startDate":"2021-08-01","conditions":"Cervical Degenerative Disc Disorder","enrollment":291},{"nctId":"NCT03756961","phase":"NA","title":"Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2019-05-01","conditions":"Obesity, Pain, Postoperative","enrollment":220},{"nctId":"NCT06788743","phase":"NA","title":"Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-06-01","conditions":"Postoperative Delirium (POD), Diabetes","enrollment":450},{"nctId":"NCT02527083","phase":"PHASE4","title":"Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain","status":"COMPLETED","sponsor":"VA Pittsburgh Healthcare System","startDate":"2015-01","conditions":"Acute Pain, Chronic Pain, Hernia","enrollment":10},{"nctId":"NCT07239479","phase":"NA","title":"DEXDES Trial: Dexmedetomidine-Desflurane Combination in Laparoscopic Colectomy","status":"RECRUITING","sponsor":"Tam Anh Research Institute","startDate":"2025-12-01","conditions":"Colorectal Neoplasms","enrollment":40},{"nctId":"NCT07296458","phase":"PHASE3","title":"FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-12-15","conditions":"Primary Biliary Cholangitis (PBC)","enrollment":132},{"nctId":"NCT02153229","phase":"PHASE2","title":"Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2014-06-02","conditions":"Epitheliod Malignant Pleural Mesothelioma","enrollment":52},{"nctId":"NCT07304479","phase":"NA","title":"Effects of Sevoflurane Versus Desflurane Anesthesia Under Protective Mechanical Ventilation for Robotic Assisted Surgery","status":"RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-05-01","conditions":"Respiratory Mechanics, Intraoperative","enrollment":50},{"nctId":"NCT06275087","phase":"NA","title":"Differences in Speed of Recovery From Anesthesia for Intraoral Surgery","status":"RECRUITING","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2024-04-10","conditions":"Intraoral Tumor","enrollment":42},{"nctId":"NCT06907537","phase":"NA","title":"A Study to Verify the Sleep-improving Effects of the Test Food Consumption","status":"COMPLETED","sponsor":"Orthomedico Inc.","startDate":"2025-04-03","conditions":"Healthy Japanese","enrollment":44},{"nctId":"NCT07097701","phase":"PHASE3","title":"An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR","status":"RECRUITING","sponsor":"Lupin Ltd.","startDate":"2025-09-03","conditions":"Myotonia","enrollment":24},{"nctId":"NCT05603832","phase":"PHASE3","title":"A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement","status":"COMPLETED","sponsor":"Arthritis Innovation Corporation","startDate":"2022-11-17","conditions":"Post Operative Pain","enrollment":151},{"nctId":"NCT07289945","phase":"PHASE3","title":"Effects of Sevoflurane vs Desflurane on Early Recovery and Cognitive Function in Elderly Patients Undergoing Scheduled Non-Cardiac Surgery","status":"COMPLETED","sponsor":"Hopital Charles Nicolle","startDate":"2024-09-15","conditions":"Early Recovery in Elderly Patients, Cognitive Function","enrollment":81},{"nctId":"NCT06624592","phase":"PHASE3","title":"Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-20","conditions":"Delirium on Emergence","enrollment":400},{"nctId":"NCT06148025","phase":"PHASE4","title":"Antibiotics and Vaccine Immune Responses Study","status":"RECRUITING","sponsor":"South Australian Health and Medical Research Institute","startDate":"2023-11-23","conditions":"Vaccine Response Impaired","enrollment":348},{"nctId":"NCT06541145","phase":"NA","title":"Bacterial Decolonization Within Dyads","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-08-21","conditions":"Bacterial Colonization","enrollment":20},{"nctId":"NCT07256171","phase":"","title":"COAST Study - Cholesterol Optimization After Stroke","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-01","conditions":"Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage","enrollment":500},{"nctId":"NCT06591455","phase":"EARLY_PHASE1","title":"A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis","status":"COMPLETED","sponsor":"Han Ying","startDate":"2024-09-14","conditions":"Primary Biliary Cholangitis (PBC)","enrollment":30},{"nctId":"NCT06731244","phase":"NA","title":"Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-10-30","conditions":"Venous Thromboembolism","enrollment":2400},{"nctId":"NCT06606899","phase":"NA","title":"A Comparison Between Oral Melatonin With Nasal Sevoflurane Versus Oral Chloral Hydrate With Nasal Sevoflurane in Sedation of Children Undergoing Brain MRI","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-09-20","conditions":"Sedation for Children Undergoing MRI","enrollment":60},{"nctId":"NCT04594694","phase":"PHASE2","title":"Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC","status":"TERMINATED","sponsor":"Intercept Pharmaceuticals","startDate":"2019-10-02","conditions":"Primary Biliary Cholangitis","enrollment":75},{"nctId":"NCT06659965","phase":"","title":"Intravenous Methocarbamol for Acute Pain After Spine Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-01-01","conditions":"Acute Post Operative Pain, Postsurgical Pain Management, Spine Surgery","enrollment":1270},{"nctId":"NCT04661358","phase":"PHASE3","title":"Fenofibrate for Prevention of DR Worsening","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2021-03-05","conditions":"Diabetic Retinopathy","enrollment":560},{"nctId":"NCT07079761","phase":"PHASE2","title":"Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-08-04","conditions":"Post Traumatic Stress Disorder","enrollment":96},{"nctId":"NCT07025005","phase":"PHASE4","title":"Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-08-30","conditions":"Peripheral Neuropathy, Multiple Myeloma, Neoplasms","enrollment":44},{"nctId":"NCT05514119","phase":"PHASE2","title":"A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2022-08-17","conditions":"Liver Transplant","enrollment":6},{"nctId":"NCT05931484","phase":"PHASE2","title":"Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.","status":"NOT_YET_RECRUITING","sponsor":"Forest Hills Lab","startDate":"2027-11-01","conditions":"Parkinson Disease","enrollment":32},{"nctId":"NCT03945825","phase":"PHASE1","title":"Flublok or Fluzone With Advax-CpG55.2 or AF03","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-06-10","conditions":"Influenza, Influenza Immunisation","enrollment":241},{"nctId":"NCT02481245","phase":"PHASE2","title":"BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-01-11","conditions":"Bipolar Disorder, Depressive Episode","enrollment":30},{"nctId":"NCT05247177","phase":"NA","title":"Multimodal GA for Lumbar Spine Surgery","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2022-03-14","conditions":"Lumbar Spine Fusion Surgery","enrollment":100},{"nctId":"NCT06343753","phase":"NA","title":"Quality of Recovery After Laparoscopic Cholecystectomy Comparing Opioid Free Analgesia Versus Opioid Free Anesthesia","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-05-01","conditions":"Quality of Recovery, Pain, Postoperative, Elective Laparoscopic Cholecystectomy","enrollment":50},{"nctId":"NCT06191133","phase":"PHASE1","title":"Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma","status":"RECRUITING","sponsor":"Lindsay Ferguson, MD","startDate":"2024-11-20","conditions":"Cervical Intraepithelial Neoplasia, Invasive Cervical Cancer","enrollment":24},{"nctId":"NCT06779890","phase":"PHASE4","title":"Effect of Volatile- Based Versus Total Intravenous Anesthesia on Brain Homeostasis and Neurocognitive Outcome","status":"RECRUITING","sponsor":"Georgia Tsaousi","startDate":"2025-05-12","conditions":"Brain Edema Caused by Drugs, Cerebral Oxygenation","enrollment":84},{"nctId":"NCT05830864","phase":"","title":"Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus","status":"COMPLETED","sponsor":"Hopital of Melun","startDate":"2024-06-30","conditions":"Refractory Status Epilepticus","enrollment":66},{"nctId":"NCT05239468","phase":"PHASE2","title":"Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC","status":"COMPLETED","sponsor":"Intercept Pharmaceuticals","startDate":"2022-03-21","conditions":"Primary Biliary Cholangitis","enrollment":72},{"nctId":"NCT07192198","phase":"PHASE2","title":"Efficacy of Inhaled Methoxyflurane (Penthrox) as Adjunct for Urologic Procedures Under Local Anesthetic: A Pilot Study","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2024-04-17","conditions":"Scrotum Disease, Hydrocele Male, Spermatocele","enrollment":40},{"nctId":"NCT07154654","phase":"","title":"Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders","status":"RECRUITING","sponsor":"Lupin Ltd.","startDate":"2025-09-30","conditions":"Myotonic Disorders","enrollment":10},{"nctId":"NCT07181564","phase":"NA","title":"Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension","status":"RECRUITING","sponsor":"University General Hospital of Patras","startDate":"2025-09-11","conditions":"Magnesium Sulfate, Remifentanil, S 100beta","enrollment":150},{"nctId":"NCT06064539","phase":"PHASE1","title":"Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-05-18","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT06832683","phase":"NA","title":"Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Kocaeli City Hospital","startDate":"2025-06-19","conditions":"Recovery Period, Hypoxemia, Patient Safety","enrollment":230},{"nctId":"NCT04726592","phase":"PHASE3","title":"Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-07-08","conditions":"Migraine, Migraine Without Aura, Migraine With Aura","enrollment":323},{"nctId":"NCT06740812","phase":"PHASE4","title":"Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-05","conditions":"Nausea and Vomiting, Nausea, Vomiting","enrollment":212},{"nctId":"NCT07152912","phase":"NA","title":"Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-09-04","conditions":"Isoflurane, Sevoflurane, Oxidative Stress","enrollment":80},{"nctId":"NCT06443606","phase":"PHASE3","title":"Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-03-27","conditions":"BPC, Non Optimal Response to UDCA","enrollment":108},{"nctId":"NCT07142408","phase":"PHASE3","title":"The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal","status":"RECRUITING","sponsor":"The Cooper Health System","startDate":"2023-03-13","conditions":"Surgical Wound Infection","enrollment":848},{"nctId":"NCT07064161","phase":"NA","title":"Efficacy of Hydrocolloid Dressing vs. Topical Antibiotic on Wound Healing of Post-Punch Biopsy Wounds","status":"COMPLETED","sponsor":"University of Santo Tomas Hospital, Philippines","startDate":"2024-01-29","conditions":"Biopsy Wound","enrollment":60},{"nctId":"NCT06287151","phase":"NA","title":"Regional Anesthesia EMG Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2023-08-09","conditions":"Surgery","enrollment":80},{"nctId":"NCT06155331","phase":"PHASE2","title":"Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-12-01","conditions":"Breast Cancer Stage 2 and 3","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"chemblId":"CHEMBL487418"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":66227,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"ETHER","genericName":"ETHER","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"Not specified","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:00:58.358366+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}